VVT Med Inc. specializes in developing minimally invasive solutions for treating varicose veins. While the company boasts a strong gross margin of 64.3%, its financial health is concerning, highlighted by a severely negative EBITDA margin and net margin, indicating significant operational challenges. Additionally, the current and quick ratios suggest liquidity issues, as both are well below 1. Despite high margins, the low market cap of $14.16M raises questions about valuation and investor confidence. Overall, VVT Med faces significant hurdles that need addressing for sustainable growth.
Loading financial metrics...
Company has $271K in cash but burned $192K last quarter. At this burn rate, only 1.4 quarters of runway remain without additional financing.
Company posted a loss of $-983K over the last year, representing 1228.8% of revenue.
Debt of $3.1M is 11.6x the company's cash position of $271K.
Exceptional gross margin of 68.8% indicates strong pricing power and competitive moat.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical Devices companies of a similar size
Based on 2025-Q2 (June 30, 2025)